Treatment of Ehlers-Danlos Syndrome Flares
For EDS flares, avoid opioids and parenteral nutrition, and instead prioritize a multidisciplinary rehabilitative approach centered on physical/occupational therapy with bracing, non-opioid pain management, and treatment of underlying triggers including autonomic dysfunction and gastrointestinal symptoms. 1, 2
Immediate Assessment During Flare
Identify the Flare Trigger
- Screen for POTS exacerbation by measuring postural vital signs with active stand test (heart rate increase ≥30 beats/min in adults within 10 minutes of standing without orthostatic hypotension), as autonomic dysfunction commonly precipitates symptom flares 2
- Evaluate for new joint subluxations or dislocations that may be driving acute pain worsening 3
- Assess for gastrointestinal symptom escalation (nausea, abdominal pain, constipation, bloating), which affects up to 98% of hypermobile EDS patients and frequently worsens during flares 2
- Rule out mast cell activation if patient presents with episodic multisystem symptoms (flushing, urticaria, wheezing) by obtaining serum tryptase during symptomatic period 2
Critical Pitfall to Avoid
- Never initiate or escalate opioids during EDS flares, as opioids worsen gastrointestinal dysmotility, increase infection risk, and have shown poor efficacy in this population 1, 4
- Avoid parenteral nutrition unless life-threatening malnutrition is present, as it should only serve as a temporary bridge to rehabilitative therapies and carries increased infection risk in EDS patients 1
First-Line Acute Flare Management
Most Effective Non-Pharmacologic Interventions
- Initiate or intensify occupational therapy with bracing, which showed 70% improvement rates in the largest treatment efficacy study—the highest success rate of any intervention 4
- Apply compression garments for joint stabilization and POTS symptom management 2
- Implement assistive devices (canes, walkers) to offload affected joints and prevent further subluxations 5
Pharmacologic Pain Management
- Use NSAIDs as first-line if no contraindications exist 5, 4
- Add acetaminophen for additional analgesia 4
- Consider topical analgesics for localized pain 5
- Trial neuropathic modulators (gabapentin, pregabalin, duloxetine) for neuropathic pain components, though note that 47% of patients report adverse effects requiring dose adjustment 4
POTS-Specific Treatment During Flares
- Increase fluid intake to 2-3 liters daily and salt intake to 10-12 grams daily as immediate interventions 2
- Implement compression garments (20-30 mmHg waist-high stockings) 2
- Consider pharmacologic volume expansion or heart rate control if conservative measures fail 2
Gastrointestinal Symptom Management
- Optimize oral nutrition with small, frequent meals and gastroparesis diet modifications if upper GI symptoms predominate 1, 2
- Trial mirtazapine (serotonergic neuromodulator) to increase food tolerance and body weight if significant GI-related weight loss is present 1
- Avoid elimination diets that may perpetuate or trigger avoidant/restrictive food intake disorder (ARFID), which has significant overlap with EDS 1
Multidisciplinary Team Coordination
Essential Team Members During Flare
- Pain physician for non-opioid medication optimization and consideration of interventional procedures 6
- Physical/occupational therapist for immediate joint stabilization strategies and proprioceptive training 4, 6, 3
- Pain psychologist for cognitive behavioral therapy addressing kinesiophobia, anxiety, and central sensitization 6, 7
- Gastroenterologist if GI symptoms are prominent or refractory 2
- Cardiologist or autonomic specialist if POTS symptoms are severe 2
Psychosocial Interventions
- Initiate or intensify cognitive behavioral therapy focusing on pain catastrophizing, kinesiophobia, and anxiety, which significantly burden EDS patients and worsen pain perception 6, 7
- Provide pain education about central sensitization mechanisms and the multifactorial nature of EDS pain 6, 7
- Teach coping and relaxation strategies as part of pain self-management 6
Emerging Therapies with Promising Evidence
- Low-dose naltrexone has shown promising effects for decreasing pain and increasing quality of life 7
- Transcutaneous electrical nerve stimulation (TENS) units demonstrate benefit for pain reduction 7
- Trigger point injections for localized myofascial pain 7
- Laser therapy shows emerging evidence for pain relief 7
- Medical marijuana was rated as extremely helpful by 10-24% of users in patient surveys, though this represents non-prescribed therapy use 8
When Interventional Procedures May Be Considered
- Selected patients may benefit from pain interventions to decrease pain intensity, contrary to historical concerns about local anesthetic resistance in EDS 6
- Ensure procedures are performed at centers with EDS expertise given tissue fragility concerns 5
Long-Term Flare Prevention Strategy
- Maintain regular physical therapy focusing on muscle strengthening to compensate for joint laxity and prevent subluxations 4, 3, 7
- Continue compression garments and bracing for joint protection during activities 2, 4
- Optimize cardiovascular conditioning through graded exercise programs to improve POTS symptoms 2
- Address sleep disturbances and fatigue, which contribute to pain amplification 7
- Maintain adequate vitamin D and calcium supplementation for bone health 5
What NOT to Do During EDS Flares
- Do not prescribe or escalate opioids, as they worsen GI dysmotility, increase infection risk, and show poor long-term efficacy 1, 4
- Do not initiate parenteral nutrition unless life-threatening malnutrition exists, and only as temporary bridge to rehabilitative therapy 1
- Do not perform invasive vascular procedures in vascular EDS patients due to fatal complication risk 2, 5
- Do not recommend prolonged bed rest, which worsens deconditioning and POTS symptoms 2
- Do not dismiss psychological comorbidities, as anxiety and panic disorders significantly amplify pain burden 6